These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23619897)

  • 1. Tumor margin detection using quantitative NIRF molecular imaging targeting EpCAM validated by far red gene reporter iRFP.
    Zhu B; Wu G; Robinson H; Wilganowski N; Hall MA; Ghosh SC; Pinkston KL; Azhdarinia A; Harvey BR; Sevick-Muraca EM
    Mol Imaging Biol; 2013 Oct; 15(5):560-8. PubMed ID: 23619897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of mAbs targeting epithelial cell adhesion molecule for the detection of prostate cancer lymph node metastases with multimodal contrast agents: quantitative small-animal PET/CT and NIRF.
    Hall MA; Pinkston KL; Wilganowski N; Robinson H; Ghosh P; Azhdarinia A; Vazquez-Arreguin K; Kolonin AM; Harvey BR; Sevick-Muraca EM
    J Nucl Med; 2012 Sep; 53(9):1427-37. PubMed ID: 22872743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Putting numbers to fluorescent guided surgery.
    Rosenthal EL; Zinn KR
    Mol Imaging Biol; 2013 Dec; 15(6):647-8. PubMed ID: 23836503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EpCAM as multi-tumour target for near-infrared fluorescence guided surgery.
    van Driel PB; Boonstra MC; Prevoo HA; van de Giessen M; Snoeks TJ; Tummers QR; Keereweer S; Cordfunke RA; Fish A; van Eendenburg JD; Lelieveldt BP; Dijkstra J; van de Velde CJ; Kuppen PJ; Vahrmeijer AL; Löwik CW; Sier CF
    BMC Cancer; 2016 Nov; 16(1):884. PubMed ID: 27842504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual-Modality Image-Guided Surgery of Prostate Cancer with a Radiolabeled Fluorescent Anti-PSMA Monoclonal Antibody.
    Lütje S; Rijpkema M; Franssen GM; Fracasso G; Helfrich W; Eek A; Oyen WJ; Colombatti M; Boerman OC
    J Nucl Med; 2014 Jun; 55(6):995-1001. PubMed ID: 24700882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging prostate cancer lymph node metastases with a multimodality contrast agent.
    Hall MA; Kwon S; Robinson H; Lachance PA; Azhdarinia A; Ranganathan R; Price RE; Chan W; Sevick-Muraca EM
    Prostate; 2012 Feb; 72(2):129-46. PubMed ID: 21538422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Near-Infrared Dye-Labeled Anti-Prostate Stem Cell Antigen Minibody Enables Real-Time Fluorescence Imaging and Targeted Surgery in Translational Mouse Models.
    Zhang M; Kobayashi N; Zettlitz KA; Kono EA; Yamashiro JM; Tsai WK; Jiang ZK; Tran CP; Wang C; Guan J; Wu AM; Reiter RE
    Clin Cancer Res; 2019 Jan; 25(1):188-200. PubMed ID: 30301826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo near-infrared fluorescence imaging of CD105 expression during tumor angiogenesis.
    Yang Y; Zhang Y; Hong H; Liu G; Leigh BR; Cai W
    Eur J Nucl Med Mol Imaging; 2011 Nov; 38(11):2066-76. PubMed ID: 21814852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescence-guided tumor detection with a novel anti-EpCAM targeted antibody fragment: Preclinical validation.
    Boogerd LSF; Boonstra MC; Prevoo HAJM; Handgraaf HJM; Kuppen PJK; van de Velde CJH; Fish A; Cordfunke RA; Valentijn ARPM; Terwisscha van Scheltinga AG; MacDonald GC; Cizeau J; Premsukh A; Vinkenburg van Slooten ML; Burggraaf J; Sier CFM; Vahrmeijer AL
    Surg Oncol; 2019 Mar; 28():1-8. PubMed ID: 30851880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycan-Based Near-infrared Fluorescent (NIRF) Imaging of Gastrointestinal Tumors: a Preclinical Proof-of-Concept In Vivo Study.
    Houvast RD; Baart VM; Bhairosingh SS; Cordfunke RA; Chua JX; Vankemmelbeke M; Parsons T; Kuppen PJK; Durrant LG; Vahrmeijer AL; Sier CFM
    Mol Imaging Biol; 2020 Dec; 22(6):1511-1522. PubMed ID: 32780212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Near-infrared fluorescence imaging of gastrin releasing peptide receptor targeting in prostate cancer lymph node metastases.
    Cai QY; Yu P; Besch-Williford C; Smith CJ; Sieckman GL; Hoffman TJ; Ma L
    Prostate; 2013 Jun; 73(8):842-54. PubMed ID: 23280511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo imaging of orthotopic prostate cancer with far-red gene reporter fluorescence tomography and in vivo and ex vivo validation.
    Lu Y; Darne CD; Tan IC; Wu G; Wilganowski N; Robinson H; Azhdarinia A; Zhu B; Rasmussen JC; Sevick-Muraca EM
    J Biomed Opt; 2013 Oct; 18(10):101305. PubMed ID: 23797877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway.
    Ni J; Cozzi P; Hao J; Beretov J; Chang L; Duan W; Shigdar S; Delprado W; Graham P; Bucci J; Kearsley J; Li Y
    Int J Biochem Cell Biol; 2013 Dec; 45(12):2736-48. PubMed ID: 24076216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deglycosylation of mAb by EndoS for improved molecular imaging.
    Gao P; Pinkston KL; Wilganowski N; Robinson H; Azhdarinia A; Zhu B; Sevick-Muraca EM; Harvey BR
    Mol Imaging Biol; 2015 Apr; 17(2):195-203. PubMed ID: 25135058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of EpCAM positive cells isolated from sentinel lymph nodes of breast cancer patients identifies subpopulations of cells with distinct transcription profiles.
    Tveito S; Andersen K; Kåresen R; Fodstad Ø
    Breast Cancer Res; 2011 Aug; 13(4):R75. PubMed ID: 21816090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimodal chelation platform for near-infrared fluorescence/nuclear imaging.
    Ghosh SC; Ghosh P; Wilganowski N; Robinson H; Hall MA; Dickinson G; Pinkston KL; Harvey BR; Sevick-Muraca EM; Azhdarinia A
    J Med Chem; 2013 Jan; 56(2):406-16. PubMed ID: 23214723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrin αvβ3-targeted IRDye 800CW near-infrared imaging of glioblastoma.
    Huang R; Vider J; Kovar JL; Olive DM; Mellinghoff IK; Mayer-Kuckuk P; Kircher MF; Blasberg RG
    Clin Cancer Res; 2012 Oct; 18(20):5731-40. PubMed ID: 22914772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using Dual Fluorescence Reporting Genes to Establish an In Vivo Imaging Model of Orthotopic Lung Adenocarcinoma in Mice.
    Lai CW; Chen HL; Yen CC; Wang JL; Yang SH; Chen CM
    Mol Imaging Biol; 2016 Dec; 18(6):849-859. PubMed ID: 27197534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantifying multimodal contrast agent biological activity using near-infrared flow cytometry.
    Hall MA; Aldrich MB; Azhdarinia A; Lachance PA; Robinson H; Hazen A; Haviland DL; Sevick-Muraca EM
    Contrast Media Mol Imaging; 2012; 7(3):338-45. PubMed ID: 22539404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical evaluation of EpCAM-binding designed ankyrin repeat proteins (DARPins) as targeting moieties for bimodal near-infrared fluorescence and photoacoustic imaging of cancer.
    Houvast RD; Badr N; March T; de Muynck LDAN; Sier VQ; Schomann T; Bhairosingh S; Baart VM; Peeters JAHM; van Westen GJP; Plückthun A; Burggraaf J; Kuppen PJK; Vahrmeijer AL; Sier CFM
    Eur J Nucl Med Mol Imaging; 2024 Jul; 51(8):2179-2192. PubMed ID: 37642704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.